Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PHC has reported that its Pivotal Research Centers has initiated its largest Phase I Alzheimer's disease trial to date for a major national sponsor.
Subscribe to our email newsletter
In collaboration with four prestigious neurologists, Pivotal has begun screening patients for the Phase I research effort, which is expected to have major implications for the treatment of Alzheimer patients. The first patient is expected in-house early April 2008. The Phase I activity will continue through July 2008.
The study will involve 21 randomized patients who, under close protocol, will reside in Pivotal’s Phase I unit for the duration of 28 days. Pivotal Research Centers will utilize its trained and experienced Phase I staff to provide the expertise required for the compliance and success of the trial.
Bruce Shear, president and CEO of Pioneer, said: “This is the first big study since we opened our new Phase I expanded 15-bed unit this fiscal year. We anticipate this study to generate approximately $0.75 millions over the next four months and boost profits in the current quarter.”